Karyopharm Therapeutics Inc (KPTI)
1.15
+0.02
(+1.32%)
USD |
NASDAQ |
May 17, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Investing (Quarterly): 21.94M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.94M |
| December 31, 2023 | 26.84M |
| September 30, 2023 | -7.685M |
| June 30, 2023 | 21.17M |
| March 31, 2023 | -32.39M |
| December 31, 2022 | -65.30M |
| September 30, 2022 | 11.67M |
| June 30, 2022 | -36.60M |
| March 31, 2022 | -14.04M |
| December 31, 2021 | 30.77M |
| September 30, 2021 | 21.43M |
| June 30, 2021 | 46.46M |
| March 31, 2021 | 43.19M |
| December 31, 2020 | 31.40M |
| September 30, 2020 | 21.43M |
| June 30, 2020 | -60.03M |
| March 31, 2020 | -46.48M |
| December 31, 2019 | -33.52M |
| September 30, 2019 | 40.18M |
| June 30, 2019 | 39.80M |
| March 31, 2019 | 31.99M |
| December 31, 2018 | -103.11M |
| September 30, 2018 | 20.57M |
| Date | Value |
|---|---|
| June 30, 2018 | -27.60M |
| March 31, 2018 | 2.484M |
| December 31, 2017 | -2.901M |
| September 30, 2017 | 20.59M |
| June 30, 2017 | -1.134M |
| March 31, 2017 | 0.549M |
| December 31, 2016 | 6.602M |
| September 30, 2016 | -4.975M |
| June 30, 2016 | 16.22M |
| March 31, 2016 | 6.751M |
| December 31, 2015 | 33.84M |
| September 30, 2015 | 44.56M |
| June 30, 2015 | 0.858M |
| March 31, 2015 | -170.08M |
| December 31, 2014 | -63.90M |
| September 30, 2014 | -2.286M |
| June 30, 2014 | -0.324M |
| March 31, 2014 | -0.525M |
| December 31, 2013 | -0.032M |
| September 30, 2013 | -0.025M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-65.30M
Minimum
Dec 2022
46.46M
Maximum
Jun 2021
3.012M
Average
21.30M
Median
Cash from Investing (Quarterly) Benchmarks
| Geron Corp | 34.21M |
| Arbutus Biopharma Corp | 11.69M |
| Verastem Inc | 30.98M |
| Actinium Pharmaceuticals Inc | -0.011M |
| Chimerix Inc | 8.675M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -43.72M |
| Free Cash Flow | -117.73M |
| Free Cash Flow Per Share (Quarterly) | -0.3804 |
| Free Cash Flow to Equity (Quarterly) | -44.13M |
| Free Cash Flow to Firm (Quarterly) | -40.18M |
| Free Cash Flow Yield | -89.25% |